Product
Detemir
Aliases
Levemir
2 clinical trials
3 indications
Indication
DiabetesIndication
ObesityIndication
Type 2 Diabetes MellitusClinical trial
Making an "Obese"Brain(and Body)Lean: Insulin Detemir,Monoamines,and RewardStatus: Active (not recruiting), Estimated PCD: 2025-12-01
Clinical trial
A 24-week, National, Single-centre, Open-labelled, Randomised, Parallel-group Trial Comparing Energy Expenditure With Insulin Detemir Versus NPH Insulin Using a Basal-bolus Regimen With Insulin Aspart as the Mealtime Insulin in Subjects With Type 2 DiabetesStatus: Completed, Estimated PCD: 2009-08-01